Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 07 Sept 2021 for EXAGEN INC., €12k. Read the official filing
Filing timeline
BuySaleWendy S. Johnson
Insider track record
Disclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-19.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Wendy S. Johnson: trading record in brief
Wendy S. Johnson is a declared insider at 2 companies (senior executive); the most frequent names are OnKure Therapeutics, Inc. and Exagen Inc. Over a trading history stretching from 8 July 2021 to 3 September 2021, the count stands at 3 filings.
In open-market terms, that means 1 purchase worth €12k on one side and 1 sale worth €803k on the other. Taken together, the sales exceed the purchases by €791k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 option exercise.
On 7 September 2021 came the latest disclosure, an open-market purchase for €12k in Exagen Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Wendy S. Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
1,000 shares@ US$14.02100.0% of flowCommon StockSEC:0001274737-21-000101:0
Canonical exit: 2 Dec 2021 (T+90)
111,736 shares@ US$8.5081.2% of flowCommon StockSEC:0001209191-21-046802:0
111,736 shares@ US$1.9718.8% of flowCommon StockSEC:0001209191-21-046254:0
3 of 3 declarations
